13 results
8-K
EX-1.1
ZIVO
Zivo Bioscience, Inc.
2 Jun 21
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
5:14pm
, and pursuant thereto the Company has developed and implement a Hazard Analysis and Critical Control Point program.
D) The Company is producing its
S-1
EX-1.1
ZIVO
Zivo Bioscience, Inc.
9 Dec 20
IPO registration
3:30pm
developed and implement a Hazard Analysis and Critical Control Point program.
(D) The Company is producing its algal biomass in compliance with standards set
- Prev
- 1
- Next